W
WLC

Topic

peptide therapy

4 articles on peptide therapy in longevity medicine. View all news →

The Guardian: Medicines watchdog to investigate UK peptide clinics over health claims Peer-reviewed

Are Longevity Clinics Regulated? What UK, EU, US, and Swiss Patients Should Know in 2026

Longevity clinics are usually regulated through doctors, medicines, devices, diagnostics, premises, and advertising claims — not as one universal clinic category.

Ars Technica: RFK Jr. forces FDA to reconsider 12 unproven peptides after 2023 ban Peer-reviewed

Peptide Therapy at Longevity Clinics: What's Legal, What Works & What's Next (2026)

Peptide therapy is the fastest-growing treatment category at longevity clinics. But RFK Jr.'s push to reclassify 12 banned peptides has created confusion. Here's which peptides clinics actually use, what the evidence says, what they cost, and how to choose a clinic.

Spannr: Peptide Therapy for Longevity: Benefits, Risks, and What's Real

Best Longevity Clinics for Peptide Therapy in 2026

With FDA peptide reclassification restoring access to 14 key peptides, longevity clinics offering peptide therapy are seeing renewed interest. Here's what to look for in a peptide clinic, which peptides are commonly offered, and how to evaluate quality and safety.

NPR: The government may soon lift restrictions on some peptide treatments Peer-reviewed

FDA Peptide Reclassification 2026: What It Means for Longevity Clinics and Patients

HHS Secretary Kennedy announced ~14 peptides will move from Category 2 (restricted) to Category 1 (legal for compounding). Here's what the reclassification means for longevity medicine, which peptides are returning, and why physician oversight matters more than ever.